+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Doses of systemic corticosteroids in hospitalised children with acute asthma: A systematic review

Doses of systemic corticosteroids in hospitalised children with acute asthma: A systematic review

Journal of Paediatrics and Child Health 42(4): 179-183

To present the doses of systemic corticosteroids reported by clinical trials in hospitalised children with acute asthma and to assess the possible relationship between doses of corticosteroids and clinical responses. An electronic search of MEDLINE databases (January 1949-February 2005) and Cochrane Controlled Clinical Trials Register (February 2005) was undertaken using a combination of indexing terms related to systemic corticosteroids and acute asthma. Studies were selected if they met the following criteria: (i) randomized controlled trial; (ii) children aged 1-18 years and admitted to hospital for acute asthma; and (iii) treatment group consisting of systemic corticosteroids. Nine trials were included for this review. There was considerable variation between the reported doses of systemic corticosteroids. Only two trials assessed clinical responses to different doses of systemic corticosteroids. Both trials failed to show any therapeutic advantage of higher doses over lower doses. The results of the two trials were not suitable for pooling. Current data are not sufficient for establishing dose-response relationship of systemic corticosteroids in hospitalised children with acute asthma. Larger randomized trials are needed.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 048827753

Download citation: RISBibTeXText

PMID: 16630318

DOI: 10.1111/j.1440-1754.2006.00826.x

Related references

Inhaled versus systemic corticosteroids for acute asthma in children. A systematic review. Pediatric Pulmonology 49(4): 326-334, 2014

Corticosteroids for hospitalised children with acute asthma. Cochrane Database of Systematic Reviews (): Cd002886-Cd002886, 2003

Inhaled corticosteroids may be superior to systemic corticosteroids in children with moderate-to-severe acute asthma. Pediatric Asthma Allergy & Immunology 16(3): 121-128, Fall, 2003

A systematic review of long-acting β2-agonists versus higher doses of inhaled corticosteroids in asthma. Pediatrics 130(3): E650-E657, 2012

A Systematic Review of Long-Acting beta2-Agonists Versus Higher Doses of Inhaled Corticosteroids in Asthma. 2012

Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database of Systematic Reviews (): Cd001740-Cd001740, 2000

High doses of systemic corticosteroids in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. A cohort study. Revista Clinica Espanola, 2017

A question of time: systemic corticosteroids in managing acute asthma in children. Current Opinion in Pulmonary Medicine 19(1): 73-78, 2013

Oral versus intravenous corticosteroids in adults hospitalised with acute asthma. Pulmonary Pharmacology & Therapeutics 18(3): 207-212, 2005

Dose response of inhaled corticosteroids in children with persistent asthma: a systematic review. Pediatrics 127(1): 129-138, 2011

Impact of Inhaled Corticosteroids on Growth in Children with Asthma: Systematic Review and Meta-Analysis. Plos One 10(7): E0133428-E0133428, 2016

Retrospective review of 200 children hospitalised with acute asthma. Identification of intervention points: a single centre study. Journal of Paediatrics and Child Health 50(4): 286-290, 2014

A 5- versus 3-day course of oral corticosteroids for children with asthma exacerbations who are not hospitalised: a randomised controlled trial. Medical Journal of Australia 189(6): 306-310, 2008

Effects of asthma and inhaled corticosteroids in children on the final adult height: a systemic review and Meta analysis. Zhongguo Dang Dai Er Ke Za Zhi 17(11): 1242-1247, 2016

Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review. Chest 139(1): 28-35, 2011